Viral protein R (Vpr) of human immunodeficiency virus type 1 induces G2 arrest in cells from distantly related eukaryotes including human and fission yeast through inhibitory phosphorylation of tyrosine 15 (Tyr15) on Cdc2. Since the DNA damage and DNA replication checkpoints also induce G2 arrest through phosphorylation of Tyr15, it seemed possible that Vpr induces G2 arrest through the checkpoint pathways. However, Vpr does not use either the early or the late checkpoint genes that are required for G2 arrest in response to DNA damage or inhibition of DNA synthesis indicating that Vpr induces G2 arrest by an alternative pathway. It was found that protein phosphatase 2A (PP2A) plays an important role in the induction of G2 arrest by Vpr since mutations in genes coding for a regulatory or catalytic subunit of PP2A reduce Vpr-induced G2 arrest. Vpr was also found to upregulate PP2A, supporting a model in which Vpr activates the PP2A holoenzyme to induce G2 arrest. PP2A is known to interact genetically in fission yeast with the Wee1 kinase and Cdc25 phosphatase that act on Tyr15 of Cdc2. Both Wee1 and Cdc25 play a role in Vpr-induced G2 arrest since a wee1 deletion reduces Vpr-induced G2 arrest and a direct in vivo assay shows that Vpr inhibits Cdc25. Additional support for both Wee1 and Cdc25 playing a role in Vpr-induced G2 arrest comes from a genetic screen, which identified genes whose overexpression affects Vpr-induced G2 arrest. For this genetic screen, a strain was constructed in which cell killing by Vpr was nearly eliminated while the effect of Vpr on the cell cycle was clearly indicated by an increase in cell length. Overexpression of the wos2 gene, an inhibitor of Wee1, suppresses Vpr-induced G2 arrest while overexpression of rad25, an inhibitor of Cdc25, enhances Vpr-induced G2 arrest. These two genes may be part of the uncharacterized pathway for Vpr-induced G2 arrest in which Vpr upregulates PP2A to activate Wee1 and inhibit Cdc25.
INTRODUCTION
In all eukaryotic cells, progression of cells from the G2 phase of the cell cycle to mitosis requires activation of the cyclin-dependent kinase Cdc2 (Morgan, 1995) . In fission yeast (Schizosaccharomyces pombe), entry into mitosis is regulated by the phosphorylation status of tyrosine 15 (Tyr15) on Cdc2, which is phosphorylated by Wee1 and Mik1 kinases during G2 and rapidly dephosphorylated by the Cdc25 phosphatase to trigger entry into mitosis (Gould and Nurse, 1989; Krek and Nigg, 1991; Morgan, 1995; Norbury et al., 1991) . These cell cycle regulatory elements are the targets of two well-characterized regulatory pathways that induce cell cycle arrest, the DNA damage and DNA replication checkpoints. The DNA damage checkpoint activated by DNA damaging agents, such as radiation or nitrogen mustard (HN 2 ), leads to inhibitory phosphorylation of Cdc2 by a pathway that appears to be highly conserved between fission yeast and mammalian cells (Nurse, 1997; O'Connor et al., 1993; Rhind and Russell, 1998a; Sanchez et al., 1997) . In fission yeast the early genes in the checkpoint pathway, which include Rad1, Rad3, Rad9, and Rad17, are thought to detect the DNA damage and lead to the phosphorylation of the Chk1 protein (Walworth and Bernards, 1996) . The activated Chk1 kinase then directly phosphorylates the Cdc25 phosphatase (Furnari et al., 1997) . The phosphorylated Cdc25 binds the Rad24/25 protein, and this complex is transported out of the nucleus to render Cdc25 inactive (Lopez-Girona et al., 1999) . DNA damage thus initiates a protein phosphorylation cascade ending in the inactivation of Cdc25, which increases inhibitory phosphorylation of Tyr15 on Cdc2 to cause G2 arrest.
Inhibition of DNA replication by hydroxyurea in fission yeast also leads to cell cycle arrest through inhibitory phosphorylation of Cdc2 (Rhind and Russell, 1998b) , and this DNA replication checkpoint pathway also appears to be highly conserved in mammalian cells (Matsuoka et al., 1998) . Parts of this DNA replication checkpoint are shared with the DNA damage checkpoint as Rad1, Rad3, Rad9, and Rad17 are required for both checkpoints in fission yeast (al-Khodairy and Carr, 1992) . However, the DNA replication checkpoint acts primarily through phosphorylation of the Cds1 kinase with minor participation of the Chk1 kinase, and neither kinase is sufficient by itself to give cell cycle arrest when DNA synthesis is inhibited (Furnari et al., 1997) . The activated Cds1 kinase inactivates Cdc25 through the same mechanism as Chk1 and may also activate the Wee1 and Mik1 kinases, which phosphorylate Tyr15 of Cdc2 (Boddy et al., 1998; Zeng et al., 1998) .
Another agent that induces G2 arrest in cells from distantly related eukaryotes including human and fission yeast is the viral protein R (Vpr) of human immunodeficiency virus type 1 (HIV-1) [(He et al., 1995; Jowett et al., 1995; Re et al., 1995; Rogel et al., 1995; Zhang et al., 1997; Zhao et al., 1996) ; for a recent review, see Zhao and Elder (2000) ]. Similar to the two checkpoint control pathways, Vpr induces G2 arrest by inhibitory phosphorylation of Cdc2 kinase in both mammalian and fission yeast cells He et al., 1995; Re et al., 1995; Zhao et al., 1996) . Furthermore, we demonstrated that the Tyr15 on Cdc2 is the sole target of Vpr during induction of G2 arrest . In an apparent difference from the checkpoints, however, the protein phosphatase 2A (PP2A) plays a major role in Vpr-induced G2 arrest. Involvement of PP2A in Vpr-induced G2 arrest was first suggested by treatment of vpr-expressing cells with okadaic acid, a potent PP2A inhibitor, which suppressed Vpr-induced G2 arrest in both human and fission yeast cells (Re et al., 1995; Zhao et al., 1996) . A gene deletion of the ppa2 for one of the catalytic subunits of S. pombe PP2A was recently shown to suppress Vpr-induced G2 arrest (Masuda et al., 2000) . PP2A is known to interact genetically with Wee1 and Cdc25 in S. pombe, and overexpression of the ppa2 gene gives G2 arrest, which confirms the role of PP2A in cell cycle G2/M control (Kinoshita et al., 1990 (Kinoshita et al., , 1993 Lee et al., 1991 Lee et al., , 1994 . Since PP2A has no known role in the checkpoint pathways, we hypothesize that Vpr induces G2 arrest through a mechanism different from the DNA damage or replication checkpoints.
To test this hypothesis, the studies reported here address four questions about Vpr-induced G2 arrest. First, is Vpr-induced G2 arrest indeed different from the DNA damage or replication checkpoints? Early studies on human cells reached opposite conclusions. Poon et al. (1997) suggested that Vpr induces G2 arrest through the DNA damage checkpoint based primarily on studies with pentoxifylline (PTX), a methyl xanthine. PTX prevents G2 arrest after DNA damage (Moser et al., 2000) , and Poon et al. (1997) found that PTX also inhibits Vpr-induced G2 arrest. In contrast, Vpr still induced G2 arrest in cells from patients with ataxia telangiectasia (AT) (Bartz et al., 1996) . These AT cells are mutant for the human homologue of fission yeast Rad3 and do not arrest in G2 in response to DNA damage (Matsuoka et al., 1998; Savitsky et al., 1995) . Thus, these data suggested that Vpr does not use the DNA damage checkpoint to induce G2 arrest. In this study, we tested the effect of PTX and the Rad3 mutant on Vpr-induced G2 arrest in fission yeast. Furthermore, the ability of Vpr to induce G2 arrest was also tested in the chk1/cds1 double-mutant strain, in which both the DNA damage and DNA replication checkpoints are abolished (Boddy et al., 1998) . Chk1 and Cds1 are thought to be the last regulatory proteins specific for the DNA damage and DNA replication checkpoints, respectively (Boddy et al., 1998; Furnari et al., 1997; Zeng et al., 1998) .
The second question is the role of the catalytic and regulatory subunits of PP2A in Vpr-induced G2 arrest. In this study, we wish to know how Vpr regulates PP2A activity. Since the regulatory subunit of PP2A determines the substrate specificity (Ogris et al., 1997) , we are also interested in testing whether mutation in a regulatory subunit of PP2A also affects Vpr-induced G2 arrest. Since okadaic acid is also a weak inhibitor of protein phosphatase 1 (PP1) (Cohen, 1989; Kinoshita et al., 1993) , the potential involvement of PP1 in Vpr-induced G2 arrest was also evaluated.
The third question concerns the role of Cdc25 and Wee1 in Vpr-induced G2 arrest. There appears to be a discrepancy between mammalian and fission yeast cells with regard to the role of Cdc25 and Wee1 in Vpr-induced G2 arrest. Studies in mammalian cells suggested that Cdc25 is involved in Vpr-induced G2 arrest (Bartz et al., 1996) , but deletion of the wee1 kinase gene was shown to block Vpr-induced G2 arrest in fission yeast (Masuda et al., 2000) . In this study, we compared the effect of a wee1/cdc25 double mutant with a wee1 deletion mutant to see whether the double mutant further reduces Vprinduced G2 arrest. We also used an in vivo assay for Cdc25 activity to determine whether Vpr inhibits Cdc25 in fission yeast.
A fourth goal of these studies was to begin to define the regulatory pathways through which Vpr inhibits Cdc2 by searching for additional cellular proteins that may participate in Vpr-induced G2 arrest. To facilitate this genetic screen, we developed a strain with an integrated copy of a mutant vpr that shows a G2 delay and used this strain to screen for genes whose overexpression either suppresses or enhances Vpr-induced G2 arrest. Among the genes isolated in this screen are one that suggests a role for Wee1 in Vpr-induced G2 arrest and one which suggests a role for Cdc25.
RESULTS
Vpr does not use the DNA damage and DNA replication checkpoints during induction of G2 arrest Since Vpr and the checkpoints for DNA damage and DNA replication all induce cell cycle arrest through phosphorylation of Tyr15 on Cdc2 (Rhind and Russell, 1998b; Nurse, 1997; Re et al., 1995; Elder et al., 2000) , Vpr might induce G2 arrest through one of the checkpoint pathways. A possible role for the DNA damage checkpoint in Vpr-induced G2 arrest was further suggested by the observation that PTX suppresses Vpr-induced G2 arrest in mammalian cells since PTX also suppresses the G2 arrest induced by DNA damage (O'Connor et al., 1993) . Similar to the finding in mammalian cells, PTX also inhibits the G2 arrest induced by Vpr in fission yeast (Fig. 1A) . Since suppression of Vpr-induced G2 arrest by PTX is a transient effect in fission yeast, it is best studied by septation index analysis, in which the fraction of cells passing mitosis remains high after vpr is expressed when PTX is present. In contrast, the untreated vpr-expressing cells gradually stop dividing (Fig. 1A) (Zhao et al., 1996) . To rule out the possibility that PTX inhibits vpr expression, an immunoblot (Fig. 1B) shows that PTX does not affect the expression of vpr so it acts by blocking the effect of Vpr on the cell cycle.
While PTX prevents Vpr-induced G2 arrest, Vpr still induced G2 arrest in cells from patients with AT (Bartz et al., 1996) . These AT cells are mutant for the human homologue of fission yeast Rad3 and do not arrest in G2 in response to DNA damage (Matsuoka et al., 1998; Savitsky et al., 1995) . To test whether a defective rad3 can block Vpr-induced G2 arrest in fission yeast, vpr was expressed in a rad3-136 mutant strain. Rad3 acts as a sensor protein early in both checkpoint pathways, and a rad3 mutation blocks the induction of G2 arrest by DNA damage or inhibition of DNA synthesis (al-Khodairy and Carr, 1992) . As in mammalian cells, expression of vpr in the rad3-136 mutant strains induced levels of G2 arrest similar to that in wild-type cells (Fig. 1C) . Consistent with an earlier report , these data indicate that Vpr is still able to induce G2 arrest even though the early checkpoint functions have been lost. To explore the possibility that Vpr acts downstream of these early checkpoint genes, vpr was expressed in strains mutant for the Chk1 and Cds1 kinases. These are thought to be the last regulatory genes specific for the DNA damage or DNA replication checkpoint, respectively (Boddy et al., 1998; Furnari et al., 1997; Zeng et al., 1998) . Our results are consistent with an independent study showing that expression of vpr in a chk1 or cds1 deletion strain induced levels of G2 arrest similar to that in wild-type ( Fig.  1C ; Masuda et al., 2000) . However, since chk1 is not only involved in the DNA damage checkpoint but also plays a role in the DNA replication checkpoint, only a chk1/cds1 double-mutant strain completely prevents G2 arrest in response to inhibition of DNA replication (Boddy et al., 1998) . Expression of vpr induced levels of G2 arrest similar to that in wild-type in the chk1/cds1 strain (Fig.  1C) . Thus, none of these mutations defective in the early or late steps of the checkpoint pathways significantly reduced Vpr-induced G2 arrest, suggesting that Vpr must use an alternative pathway to induce G2 arrest.
Vpr upregulates PP2A and mutations in genes coding for subunits of PP2A reduce Vpr-induced G2 arrest
Other evidence suggesting that Vpr-induced G2 arrest is different from the checkpoints came from treatment of vpr-expressing cells with okadaic acid, a potent PP2A inhibitor and a weaker inhibitor of PP1 (Cohen, 1989; Kinoshita et al., 1993) . Okadaic acid transiently suppressed Vpr-induced G2 arrest in both mammalian and fission yeast cells (Re et al., 1995; Zhao et al., 1996) . (Table 1) were transformed with the vpr expression plasmid and the effect of Vpr expression on the cell cycle was determined by flow cytometry. The extent of G2 arrest was calculated as the percentage of G1 cells in the vpr-OFF population that shifts to G2 after vpr gene induction (vpr-ON). The level of G2 arrest induced by Vpr in a mutant strain shown in (C) is expressed as a ratio between the values for the mutant (Mt) strain and the wild-type (Wt) strain. The mean value and standard deviation (SD) are based on at least three independent measurements. No statistically significance differences from the wild-type value were found in the mutant strains.
These data suggested that both PP2A and PP1 might be involved in Vpr-induced G2 arrest. Indeed, a deletion of the gene (ppa2) for one of the catalytic subunits of PP2A was recently shown to suppress Vpr-induced G2 arrest (Masuda et al., 2000) . Here, we determined whether Vpr upregulates PP2A. Furthermore, since the regulatory subunit of PP2A normally determines the substrate specificity, we also asked whether a mutation in a regulatory subunit of PP2A also affects Vpr-induced G2 arrest.
To test the role of PP1 in Vpr-induced G2 arrest, strains with mutations in genes coding for PP1 subunits were examined. Fission yeast contains two genes (dis2 and sds21) encoding PP1, and deleting both PP1 genes results in lethality (Ohkura et al., 1989) . Vpr expression was, therefore, tested in strains with each individual gene deleted. Vpr was able to induce G2 arrest in each individual PP1 mutant strain at levels that are indistinguishable from those in wild-type cells, suggesting that PP1 is not involved in Vpr-induced G2 arrest (data not shown).
There are four genes in fission yeast encoding PP2A subunits. Two genes (ppa1 and ppa2) encode the catalytic subunit of PP2A and two other genes (paa1 and pab1) encode the regulatory subunits of PP2A (Kinoshita et al., 1990) . Vpr-induced G2 arrest in PP2A-deficient mutants was quantified and compared with G2 arrest induced by Vpr in the wild-type cells. Since a double deletion of ppa1 and ppa2 is lethal (Kinoshita et al., 1990) , expression of Vpr cannot be tested in a strain with no PP2A activity, but Vpr expression was tested in strains with each individual gene deleted. No significant reduction of Vpr-induced G2 arrest was observed in the ppa1 deletion strain. In contrast, a significant reduction of Vpr-induced G2 arrest (P Ͻ 0.004) was found in the ppa2 deletion strain ( Fig. 2A ). Septation index analysis, which measures the percentage of cells passing through mitosis (Alfa et al., 1993) , was also used to test the mutant effect of ppa2 (Fig. 2B ). There are normally 10-15% of cells passing through mitosis in an asynchronized log-phase cell culture as measured by the septation index since the septum is present for only a short period of time after mitosis is completed. As shown in Fig. 2B , both the wild-type and the ppa2⌬ mutant cells with vproff have this normal level of septated cells. However, expression of vpr in the wild-type cells arrested the cell cycle as indicated by a decreased frequency of septated cells ( Fig. 2B, left ; Zhao et al., 1996) . In contrast, ppa2⌬ cells continued through the cell cycle even in the presence of Vpr, supporting the conclusion that mutation in the catalytic subunit of PP2A suppresses Vpr-induced G2 arrest ( Fig. 2B ; Masuda et al., 2000) . It is noted that there is a quantitative difference between the flow cytometric analysis and other methods based on septation index and cell length ( Fig. 2B; Masuda et al., 2000) . This discrepancy is most likely due to an increased susceptibility of the ppa2⌬ cells to the cell killing effect of Vpr during flow cytometric analyses.
Since the ppa2 gene produces the majority of the PP2A activity in fission yeast cells (Kinoshita et al., 1990) , these data suggested that PP2A might be upregulated by Vpr during induction of G2 arrest. To test this idea, the levels of Ppa2 protein were determined by immunoblot analysis as described by Kinoshita et al. (1993) . An elevated Ppa2 protein level was observed in cell extracts isolated from the vpr-expressing (vpr-ON) cells (Fig. 2C,  right) . The level of Ppa2 protein was found to be approximately fourfold higher in the vpr-ON cells than in the vpr-repressing (vpr-OFF) cells (Fig. 2C, left) .
There are two regulatory subunits of PP2A, the PR65 or A subunit and the PR55 or B subunit. Both of these regulatory subunits are encoded by single genes, designated paa1 and pab1, in fission yeast (Kinoshita et al., 1996) . Deletion of paa1 is lethal with defects in the actin and microtubule cytoskeleton. A deletion of pab1 also causes defects in the cytoskeleton as well as other defects including a delay in cytokinesis but is viable (Kinoshita et al., 1996) . The pab1 deletion significantly reduced Vpr-induced G2 arrest to a level about a third lower than in the wild-type strain ( Fig. 2A ; P Ͻ 0.03). The effect of the pab1 deletion was confirmed by measurement of cell length indicating that there is no significant difference in cell length between vpr-repressed (7.1 Ϯ 1.4 m) and vpr-expressing (8.9 Ϯ 2.6 m) pab1 cells (Fig.  2D) . In contrast, the wild-type strain has the longer cells expected for G2 arrest, with the vpr-expressing cells (15.5 Ϯ 5.1 m) being two times longer than the vprrepressing cells (7.8 Ϯ 1.4 m). The similarity between vpr-repressing and vpr-expressing pab1 cells was also supported by measurement of the total cell size by forward-scatter analyses (Fig. 2E ).
Vpr induces G2 arrest through both Wee1 and Cdc25
Only three enzymes in fission yeast have major activities on Tyr15 phosphorylation of Cdc2, the Wee1 and Mik1 kinases and the Cdc25 phosphatase, with the Pyp3 phosphatase having weak activity (Lundgren et al., 1991; Millar et al., 1991 Millar et al., , 1992 . The vpr gene was expressed in strains in which the gene for each of three major enzymes was deleted.
Of the two kinases that phosphorylate Tyr15, the Wee1 kinase is more active than the Mik1 kinase in the normal cell cycle (Lundgren et al., 1991) . The expression of vpr in a mik1 deletion strain gives levels of G2 arrest equivalent to a wild-type strain, but a wee1 deletion significantly reduces the G2 arrest to about a third of wild-type (P Ͻ 0.003; Fig. 3A) . Comparison of vpr-expressing and vprrepressing wee1⌬ cells showed no significant difference in cell length and volume as measured by forward-scatter analysis, confirming the suppression of Vpr-induced G2 arrest in this genetic background ( Fig. 3B ; Masuda et al., 2000) . Therefore, Vpr induces G2 arrest predominately through the Wee1 kinase in fission yeast.
The residual G2 arrest in the wee1 deletion strain indicates that at least one other gene also plays a minor role. Since Cdc2 is normally regulated by the balance between Wee1 and Cdc25 activities, this other gene is likely to be cdc25 (Bartz et al., 1996) . However, a deletion of cdc25 by itself is lethal due to terminal G2 arrest so this deletion was tested in a strain mutant for both wee1 and cdc25, and a further reduction of Vpr-induced G2 arrest was observed with only 17% of the G1 cells shifting to G2 (P Ͻ 0.006; Fig. 3A ). This additional reduction of Vpr-induced G2 arrest in the double mutant compared to the wee1 mutation alone (34%) suggests that inhibition of Cdc25 plays a role in Vpr-induced G2 arrest.
This possible role for Cdc25 in Vpr-induced G2 arrest is supported by a direct in vivo assay for Cdc25 activity. This Cdc25 assay (Furnari et al., 1997 ) uses a strain with a mik1 deletion and the temperature-sensitive wee1-50 mutation so that both kinases are inactive at the restrictive temperature. Under these conditions, phosphate is no longer added to Tyr15 of Cdc2 so that the activity of the Cdc25 phosphatase alone controls the level of Tyr15 phosphorylation. Since removal of the inhibitory phosphate from Tyr15 leads to mitosis and cell division, the removal of phosphate from Tyr15 can be followed by increased septation as the cells divide. In this assay, inactivation of Cdc25 leads to a delay in septation of about 90 min (Lundgren et al., 1991) , and this assay has been used to show that both the DNA damage and the DNA replication checkpoints inhibit Cdc25 (Furnari et al., 1997 .
When this in vivo Cdc25 assay is applied to Vpr, it is found that Vpr delays septation (Fig. 3C) . These experi- (Table 1) , and the effect of vpr expression on the cell cycle was determined by flow cytometry as described in the legend to Fig. 1 . The asterisk indicates a statistically significant difference by the t test from the wild-type value at a confidence level of P Ͻ 0.03. (B) Suppression of Vpr-induced cell cycle arrest by the ppa2⌬ mutation as measured by septation index analysis. Typically, there are only 10-15% of cells passing through mitosis as determined by formation of septa. While expression of vpr in the ppa2⌬ strain does not affect the septation index (right), the percentage of cycling cells in the wild-type strain decreases after vpr expression (left). (C) Immunoblot analysis of PP2A. Protein extracts were prepared at the onset of Vpr induction (vpr-OFF) (lane 1) and 24 h after Vpr induction (vpr-ON, lane 2). Equal amount of total proteins, which were determined by the BCA protein assay (Pierce Inc., Rockford, IL), were loaded in each lane. This was further confirmed by a protein loading control (Ctr), which is a nonspecific protein that cross-reacts with the antibodies. (D) The pab1 mutation prevents the increase in cell length characteristic of cell cycle arrest as shown by measurements of cell length and (E) by forward-scatter analyses of 1 ϫ 10 4 cells.
ments were done with mutant E25Kvpr and F34Ivpr to minimize complications from the cell killing effect of Vpr since these two Vpr mutants reduce cell killing without affecting the induction of G2 arrest (Chen et al., 1999) . As shown in Fig. 3C , the vpr-OFF control cells entered mitosis, which was indicated by the percentage of septation increase, approximately 40 min after the shift to the restrictive temperature of 37°C. In contrast, upon expression of either E25Kvpr or F34Ivpr, no increase in septation is seen until 80 or 120 min after the shift. This delay in entering mitosis upon expression of vpr indicates that Vpr inhibits Cdc25. A role for Cdc25 in Vpr-induced G2 arrest is further supported by the finding that overexpression of a Cdc25 inhibitor (Rad25) enhances Vpr-induced G2 arrest (see below).
Suppression or enhancement of Vpr-induced G2 arrest in a strain where the only major effect of Vpr is on the cell cycle
To identify additional cellular proteins that potentially function along the pathway by which Vpr induces G2 arrest, we conducted a genetic screen to search for multicopy Vpr suppressors and enhancers. This search is based on the rationale that these suppressors and enhancers may represent two types of proteins regu- (Table 1) were transformed with the vpr expression plasmid, and the effect of vpr expression on the cell cycle was determined by flow cytometry as described in the legend to Fig. 2 . The t test was used to determine statistical significance, and the asterisk indicates a statistically significant difference from the wild-type value for Vpr-induced G2 arrest at a confidence level of P Ͻ 0.03. (B) A wee1 deletion prevents increased cell length after vpr expression. No significant difference in cell length and volume was found between vpr-OFF and vpr-ON populations in the wee1 deletion strain by forward-scatter analysis of 1 ϫ 10 4 cells. (C) Vpr inhibits Cdc25. A wee1-50 mik1⌬ strain carrying F34Ivpr (RE62; a) or E25Kvpr (RE60; b) in the YZ1N vector was grown for 25 h at 25°C in media with or without thiamine and then shifted to 35°C. Measurement of the septation index beginning at the time of the temperature shift shows that the increase in septation is delayed when vpr is expressed, indicating that Vpr inhibits Cdc25. lated by Vpr during the induction of G2 arrest. The suppressors would be expected to include proteins inhibited by Vpr during induction of G2 arrest. When overexpressed, a protein from this class would overcome the inhibition by Vpr (Vpr suppressors), and this suppression would be indicated by shortening of the cells. The Vpr enhancers would be expected to include proteins required by Vpr to induce G2 arrest. Overproduction of these proteins would most likely enhance the Vpr effect (Vpr enhancers), and this enhancement would be indicated by even longer cells.
However, a search for G2-specific Vpr suppressors or enhancers is complicated by the fact that Vpr displays multiple activities including cell killing and morphological changes in addition to G2 arrest Zhao et al., 1996 Zhao et al., , 1998b . Expression of vpr from a multicopy plasmid could potentially further mislead our search results because the level of vpr expression does not represent a typical physiological condition, in which most of the cellular proteins are encoded by a singlecopy gene. Since Vpr-induced cell death and G2 arrest are two independent activities of Vpr (Chen et al., 1999; Elder et al., 2000) , complications from the multiple activities of Vpr have been circumvented by expressing a vpr mutant (F34I), in which the cell killing effect of Vpr is nearly eliminated but Vpr still affects the cell cycle (Vodicka et al., 1998; Chen et al., 1999) . Expression from a single copy was achieved by integrating the gene into the yeast chromosome, which will lower its expression to a level more typical of a cellular gene, further minimizing cell killing and morphological changes. Expression from the integrated copy will also be more stable and uniform compared to expression from a plasmid whose copy number varies from cell to cell. To create this strain, the F34Ivpr mutant gene was integrated as a single copy into the yeast genome at the ura4 gene locus and the resulting strain is designated as RE076. As expected, cell killing was no longer significant in the RE076 strain, but the integrated F34I vpr in RE076 still induces G2 arrest as assayed by flow cytometry at a level (79 Ϯ 3.8%, standard deviation of three independent experiments; Fig. 4A , top) similar to that induced by wild-type multiple-copy Vpr (78 Ϯ 0.4%). Moreover, Vpr-induced G2 arrest by F34Ivpr can now be readily scored by cell elongation during log-phase growth without complications from cell killing and morphological changes. As shown in Fig. 4A (bottom), F34Ivpr-expressing cells induced the cell elongation typical of a cell cycle G2/M arrest or delay, which is commonly known as the "cdc" phenotype. Cell length measurements indicated that vpr-repressing cells had an average cell length of 10.7 Ϯ 0.4 m (Fig. 4A, bottom  left) , which increased in the vpr-expressing cells to an average length of 18.0 Ϯ 0.7 m (Fig. 4A, bottom, right) during log-phase growth.
The screen for multicopy Vpr suppressors and enhancers was done by expressing a fission yeast cDNA library in the RE076 strain, and cell length after expression of F34Ivpr was used to identify suppressor and enhancer candidates. One of the cDNA clones (Vsp21D4; Fig. 4B-d) exhibited a much shorter "wee" phenotype when overexpressed, suggesting that this protein is a Vpr suppressor. DNA sequencing showed that Vsp21D4 Cell elongation, i.e., the "cdc phenotype," induced by Vpr. Two genes whose overexpression affects Vprinduced G2 arrest. a and b are the RE076 strain with a single, integrated copy of F34Ivpr transformed with the YZ1N vector. c and d are the RE076 strain transformed with a plasmid containing wos2 cDNA whose overexpression suppresses Vpr-induced G2 arrest. e and f are the RE076 strain transformed with a plasmid containing rad25 cDNA whose overexpression enhances Vpr-induced G2 arrest.
is Wos2, a recently identified multicopy Wee1 suppressor with significant homology to human p23, an Hsp90-associated cochaperone (Munoz et al., 1999) . Wos2 interacts both functionally and physically with Cdc2 in vitro, suggesting that Wos2 may participate in regulation of the cell cycle as a downstream inhibitor of Wee1 (Munoz et al., 1999) . The suppression by Wos2 supports the conclusion that Wee1 plays an important role in Vpr-induced G2 arrest.
Overexpression of another cDNA clone (Vsp77D9) gave longer cells (Fig. 4B-f ) than the control (Fig. 4B-b) , suggesting that this gene is a multicopy Vpr enhancer. DNA sequencing of this gene indicated that Vsp77D9 encodes a Cdc25 inhibitory protein, Rad25. The rad25 gene is a sibling gene of rad24 and a human 14-3-3 homologue, which are thought to inhibit Cdc25 by exporting a phosphorylated form of Cdc25 from the nucleus (Lopez-Girona et al., 1999; Zeng et al., 1998) . The identification of a Cdc25 inhibitor as an enhancer of Vprinduced G2 arrest is further support for Cdc25 playing a role in Vpr-induced G2 arrest.
DISCUSSION
In this report, we showed that even though Vpr, DNA damage, and DNA replication checkpoints all act through phosphorylation of Tyr15 on Cdc2 (Re et al., 1995; Nurse, 1997; Rhind and Russell, 1998b; Elder et al., 2000) and PTX inhibits Vpr-induced G2 arrest and the checkpoints ( Fig. 1A ; O'Connor et al., 1993; Poon et al., 1997) , Vpr does not appear to use any part of the checkpoint pathways to induce G2 arrest in fission yeast. This idea is strongly supported by our findings and those of others that none of the mutants affecting early or late steps of the checkpoint pathways, including rad3 and chk1 (Fig. 1C) , significantly reduced Vpr-induced G2 arrest Masuda et al., 2000) . The demonstration that Vpr induces wild-type levels of G2 arrest in the chk1/cds1 double-mutant strain (Fig. 1C) provided even stronger evidence to support this conclusion because double mutations of chk1 and cds1 completely abolish the G2 checkpoint responses to DNA damage and inhibition of DNA synthesis and Chk1 and Cds1 kinases are thought to be the last steps specific to these two checkpoint pathways (Boddy et al., 1998) .
The results presented here provide further support for PP2A playing an important role in Vpr-induced G2 arrest (Re et al., 1995; Zhao et al., 1996; Masuda et al., 2000) . In agreement with Masuda et al. (2000) , we showed that a deletion of the gene for the most abundant catalytic subunit of PP2A (ppa2) reduces Vpr-induced G2 arrest ( Figs. 2A and 2B) . We further extended this finding and showed that Vpr upregulates PP2A by increasing the protein level of Ppa2 (Fig. 2C) . It is likely that the upregulation of PP2A by Vpr is a direct effect rather than an indirect effect of the cell cycle stage since Kinoshita et al. (1990) have shown that PP2A activity does not vary during the cell cycle. In addition, we demonstrated that a deletion of the gene for a regulatory subunit (pab1) also reduces Vpr-induced G2 arrest (Figs. 2D and 2E ). Since the regulatory subunit of PP2A determines the substrate specificity of PP2A (Ogris et al., 1997) , this result suggests that the downstream effectors that are regulated by PP2A are likely to be specific substrates for PP2A as determined by the regulatory subunit of PP2A during induction of G2 arrest by Vpr. These specific substrates could include Wee1 and Cdc25, because both Wee1 and Cdc25 are known substrates for PP2A (Mueller et al., 1995; Tang et al., 1993; Karaiskou et al., 1999; Che et al., 1998) .
For two reasons it is currently not clear whether PP2A is exclusively or only partially responsible for the induction of G2 arrest by Vpr. First, since vpr expression cannot be tested in a strain completely lacking PP2A activity, the contribution of PP2A to G2/M control may be underestimated. Second, although all assays indicate that a ppa2 deletion or inhibition by okadaic acid suppresses Vpr-induced G2 arrest, the extent of suppression depends on the assay with flow cytometry giving the lowest estimate (Fig. 2A) . The quantitative difference between Vpr suppression measured by the flow cytometric analysis and that given by septation index may be due to an increased susceptibility of the ppa2⌬ cells to the cell killing effect of Vpr. This increased susceptibility would have more of an effect on the flow cytometric analyses, which require longer culture times than the septation index, and the flow cytometry analyses may then underestimate the suppression by ppa2⌬. Altogether, these data strongly suggest that activation of PP2A is at least part of the pathway by which Vpr induces G2 arrest.
The results presented here indicate that both Wee1 and Cdc25 are important to Vpr-induced G2 arrest, which may help to clarify the earlier findings that Cdc25 seems to be involved in the Vpr-induced G2 arrest in mammalian cells (Bartz et al., 1996) , but a deletion of wee1 blocked Vpr-induced G2 arrest in fission yeast cells (Masuda et al., 2000) . When the contribution of Wee1 and Cdc25 to the G2 arrest induced by Vpr was quantified by flow cytometric analyses, it showed that a deletion of wee1 reduces Vpr-induced G2 arrest by two-thirds (Fig.  3A) , indicating that Wee1 plays a predominant role. The other one-third is probably contributed by inhibition of Cdc25 because double mutations of wee1-50/cdc25⌬ further reduced Vpr-induced G2 arrest (Fig. 3A) . Involvement of Cdc25 in Vpr-induced G2 arrest was further demonstrated by using a standard in vivo assay for the measurement of Cdc25 phosphatase activity in fission yeast where inhibition of Cdc25 is indicated by a delay in when cells enter mitosis (Furnari et al., 1997) . When this assay was applied to vpr-expressing cells (Fig. 3C) , a significant delay in entering mitosis was observed, indi-cating that Vpr does inhibit Cdc25. Thus, Vpr induces G2 arrest in fission yeast through both Wee1 and Cdc25.
The construction of a strain with a single integrated copy of F34Ivpr (RE076) where the only major effect of Vpr is on the cell cycle allows many of the techniques for studying the cell cycle of fission yeast to be applied to Vpr-induced G2 arrest (Fig. 4A ). This strain has been used here to screen for genes whose overexpression either enhances or suppress the effect of Vpr on the cell cycle, which may identify genes activated or inhibited by Vpr to induce G2 arrest. Two of the candidates characterized here are Wos2, which suppresses ( Fig. 4Bc-d) , and Rad25, which enhances ( Fig. 4Be-f ) Vpr-induced G2 arrest. Since Wos2 is an inhibitor of Wee1 (Munoz et al., 1999) and Rad25 is an inhibitor of Cdc25 (Lopez-Girona et al., 1999; Zeng et al., 1998) , these results are additional evidence that Vpr induces G2 arrest through both Wee1 and Cdc25. In addition, Masuda et al. (2000) have shown that a mutation in rad24, a homologue of rad25 (Ford et al., 1994) , suppresses Vpr-induced G2 arrest. The suppression by a rad24 mutation and enhancement by overexpression of rad25 indicate that these genes are strong candidates to be part of the pathway by which Vpr induces G2 arrest. Since the rad24/25 genes regulate Cdc25 by translocating it to the cytoplasm (Lopez-Girona et al., 1999; Zeng et al., 1998) , the possible involvement of rad24/25 in turn suggests that Vpr may change the cellular location of Cdc25.
In summary, the evidence presented here indicates that Vpr does not induce G2 arrest through the DNA damage and DNA replication checkpoints, and we propose that Vpr uses an alternative regulatory pathway to induce G2 arrest as depicted in the working model shown in Fig. 5 . Expression of vpr in fission yeast cells activates PP2A activity either by direct association with the PP2A enzyme complex or by association with an intermediate protein(s) X. A protein phosphorylation cascade (depicted as "?") including PP2A is probably ultimately responsible for activation of Wee1 and inhibition of Cdc25 by altering their phosphorylation levels, which leads to inhibition of Cdc2 by Tyr15 phosphorylation. Since overexpression of Rad25, a Cdc25 inhibitor, showed a synergistic effect on Vpr, Rad25 might be required by Vpr to inhibit Cdc25. Similarly, since overexpression of Wos2, a Wee1 inhibitor, suppresses the effect of Vpr on the cell cycle, Vpr might inhibit Wos2 during the induction of G2 arrest. Since Wos2 physically interacts with Cdc2 (Munoz et al., 1999) , Wos2 might be a downstream inhibitor of Wee1 by physically blocking the Tyr15 phosphorylation site on Cdc2. Vpr might then inhibit Wos2 by preventing Wos2 from binding to Cdc2 (Fig. 5) . Although PP2A is part of this proposed regulatory pathway, it is not yet known whether it is completely or only partially responsible for Vpr-induced G2 arrest. Other protein kinases and phosphatases may also be regulated by Vpr to induce G2 arrest in fission yeast.
MATERIALS AND METHODS
Cell growth, vpr gene induction, and measurement of effect on cell cycle Genotypes and sources of S. pombe strains and plasmids used in this study are summarized in Table 1 . The vpr genes were inserted into the leu1-selectable plasmids pYZ1N except for the integrated vpr gene described below for which a ura4 selection marker was used (Maundrell, 1993; Zhao et al., 1998b) . Fission yeast cells carrying the leu1-selectable plasmids were maintained on agar plates of standard Edinburgh minimal medium (EMM) supplemented with adenine and uracil at 75 g/ml and thiamine added at 20 M to repress vpr expression from the nmt1 promoter as described previously (Maundrell, 1993; Zhao et al., 1996 Zhao et al., , 1998a . The strain carrying the ura4-selectable integrated plasmid was maintained on similar medium containing adenine and leucine at 75 g/ml. Cells were grown at 30°C with constant shaking at 200 rpm except for the ⌬cdc25/ wee1-50 strain carrying the temperature-sensitive mutation wee1-50, which was grown at 35°C. For vpr induction in liquid medium, cells containing the vpr plasmid were first grown to stationary phase in the presence of 20 M thiamine. Cells were then washed three times with distilled water and diluted to a final concentration of approximately 2 ϫ 10 5 cells/ml in 10 ml of the appropriately supplemented EMM with or without thiamine.
Measurement of cell cycle G2 arrest
The strongly regulated nmt1 (no message in thiamine) promoter (Maundrell, 1993; Zhao et al., 1996) allows expression of the vpr gene to be turned OFF or ON simply by adding or removing thiamine from the growth medium. Using this inducible vpr gene expression system, Vprinduced G2 arrest can be measured in fission yeast by a number of procedures including DNA content by flow cytometry, septation index, and cell elongation by forward scatter analysis or direct visualization by microscopy (Masuda et al., 2000; Zhang et al., 1997; Zhao et al., 1996 Zhao et al., , 1998b . One indication of Vpr-induced G2 arrest is cell elongation, which is normally the result of a cell cycle G2/M delay or arrest and is commonly known as the "cdc phenotype" (Lee and Nurse, 1988; Nurse et al., 1976; Masuda et al., 2000) . For example, in thiaminecontaining growth medium (vpr gene expression is OFF), fission yeast cells with a vpr plasmid are of normal length, which ranges from 7 to 12 m (Zhao and Lieberman, 1995) , but in thiamine-free medium (vpr-ON), cells are about 16-18 m in length (Zhao et al., 1996) . Another way to examine the effect of Vpr on cell length is to use forward-scatter analysis from flow cytometry in which cell elongation and gross enlargement of vpr-ON and vpr-OFF cells are measured in a population of 10,000 cells (Zhao et al., 1996 (Zhao et al., , 1998b . To quantify the degree of Vpr-induced G2, flow cytometric analyses of cultures grown in low-nitrogen medium are normally used (Zhao et al., 1996) . Typically, 70-80% of the synchronized G1 cell population in vpr-OFF cells will shift to the G2 phase after vpr is expressed. The extent of Vpr-induced G2 arrest as measured by flow cytometry is expressed as the percentage of G1 cells in the vpr-OFF cultures that shift to G2 when vpr is expressed. To compare the extent of Vpr-induced G2 arrest in different genetic backgrounds, Vpr-induced G2 arrest in the mutant cells was normalized to the value for the wild-type strain done in parallel in each experiment so that wild-type and a mutation not affecting Vpr-induced G2 arrest have a value of 100%. As an alternative measurement, Vpr-induced G2 arrest can also be quantified by septation index analysis, which measures the percentage of cells passing mitosis as shown by formation of a septum between the dividing daughter cells, an indication of cell cycling (Alfa et al., 1993; Zhao et al., 1996) . The septa are visualized by staining with Calcofluor (Sigma F6259). Normally 10-15% of cells contain septa in an actively growing S. pombe culture, which decreases to less than 5% when vpr is expressed (Zhao et al., 1996) .
Construction of a S. pombe strain with a single integrated copy of F34Ivpr
The F34Ivpr gene along with the nmt1 promoter was removed from the F34Ivpr-YZ1N plasmid (Chen et al., 1999) by digestion with BamHI and PstI enzymes and inserted into the ura4-selectable pRIP4 vector (Maundrell, 1993 ) digested with the same enzymes. Following the procedure of Keeney and Boeke (1994) , the F34Ivpr-pRIP4 plasmid was targeted to the ura4 locus by digestion with StuI and used to transform SP223. The ura ϩ transformants were screened for sensitivity to 5-fluorouracil (Grimm et al., 1988) to identify those with integrated plasmid. Integration of the plasmid was confirmed by PCR and sequencing of the junction regions between the plasmid and DNA flanking the ura4 locus. PCR used the primers UpL (TGAGCAAACTGCTTTTGTGG) and DnR (TTCAAACTCCCTCTCAGCGT) in the flanking DNA and UpR (AGGAAATGAAACAACCGCTG) and DnL (TGTG-GAATTGTGAGCGGATA) in the plasmid DNA. The pairs of primers used in PCR were UpL-DnR, DnL-UpR, UpL-DnL, and UpR-DnR. During this analysis, it was found that the ura4 fragment in pRIP4 has an orientation opposite to that indicated in Maundrell (1993) . The strain shown to have a single integrated copy of the F34Ivpr-pRIP4 plasmid is named RE076.
Pentoxifylline treatment and Vpr expression analyses
Both immunoblotting for Vpr and pentoxifylline treatment have been described previously (Zhao et al., 1996 (Zhao et al., , 1998b . Briefly, pentoxifylline (1-(5Ј-oxohexyl)-3,7-dimethylxanthine, Sigma P1784), dissolved in distilled water as a stock solution (20 mM), was diluted to the final concentration of 5 mM in EMM. The anti-Vpr and anti-Ppa2 sera used in this study were gifts from Nathaniel R. Landau of New York University and Mitsuhiro Yanagida of Tokyo University, respectively.
